ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,572.85
      0.10%
      US Tech 100
      19,963.60
      0.59%
      Dow Jones
      39,344.79
      -0.08%
      Brent Oil
      85.285
      -0.15%
      Bitcoin
      57,351.44
      1.14%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Italy
      5. BIT

      6. Biogen Inc (1BIIB) Quote

      Biogen Inc

      Biogen Inc (1BIIB)

      BIT
      214.50
      0.00
      (0.00%)
      Closed July 09 11:30AM
      Delayed by 15 minutes

      Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

      Premium

      Key stats and details

      Current Price
      214.50
      Bid
      208.40
      Ask
      216.00
      Volume
      0.00
      0.00 Day's Range 0.00
      177.65 52 Week Range 244.60
      Market Cap
      31.231B
      Previous Close
      214.50
      Open
      -
      Last Trade
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      35
      Shares Outstanding
      145,596,895
      Dividend Yield
      -
      PE Ratio
      28.60
      Earnings Per Share (EPS)
      7.97
      Revenue
      9.84B
      Net Profit
      1.16B

      About Biogen Inc

      Sector
      Biological Pds,ex Diagnstics
      Industry
      Biological Pds,ex Diagnstics
      Website
      www.biogen.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      1970
      Biogen Inc is listed in the Biological Pds,ex Diagnstics sector of the Italian Stock Exchange with ticker 1BIIB. The last closing price for Biogen was 214.50 €. Over the last year, Biogen shares have traded in a share price range of 177.65 € to 244.60 €.

      Biogen currently has 145,596,895 shares outstanding. The market capitalization of Biogen is 31.23 € billion. Biogen has a price to earnings ratio (PE ratio) of 28.60.

      1BIIB Latest News

      More News

      Biogen Completes Acquisition of Human Immunology Biosciences

      Biogen Completes Acquisition of Human Immunology Biosciences CAMBRIDGE, Mass., July 02, 2024 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) has completed the acquisition of Human Immunology...

      July 02 2024
      GlobeNewswire Inc.

      “LEQEMBI®” (Lecanemab) for the Treatment of Alzheimer’s Disease Launched in China

      “LEQEMBI®” (Lecanemab) for the Treatment of Alzheimer’s Disease Launched in China China is the Third Country to Launch LEQEMBI Following the United States and JapanTOKYO and CAMBRIDGE, Mass...

      June 27 2024
      GlobeNewswire Inc.

      TOFIDENCE™ (tocilizumab), a Biosimilar Referencing ROACTEMRA®, Approved in the European Union

      TOFIDENCE™ (tocilizumab), a Biosimilar Referencing ROACTEMRA®, Approved in the European Union TOFIDENCE™ complements existing portfolio of immunology biosimilars commercialized by Biogen...

      June 24 2024
      GlobeNewswire Inc.

      FDA Accepts Eisai’s Filing of LEQEMBI® (lecanemab-irmb) Supplemental Biologics License Application for IV Maintenance Dosing for the Treatment of Early Alzheimer’s Disease

      FDA Accepts Eisai’s Filing of LEQEMBI® (lecanemab-irmb) Supplemental Biologics License Application for IV Maintenance Dosing for the Treatment of Early Alzheimer’s Disease TOKYO and...

      June 09 2024
      GlobeNewswire Inc.

      Biogen Receives European Commission Approval for QALSODY® (tofersen), the First Therapy to Treat a Rare, Genetic Form of ALS

      Biogen Receives European Commission Approval for QALSODY® (tofersen), the First Therapy to Treat a Rare, Genetic Form of ALS SOD1-ALS is a devastating, uniformly fatal, and ultra-rare genetic...

      May 30 2024
      GlobeNewswire Inc.

      Biogen Bolsters Late-Stage Pipeline, Expands Immunology Portfolio with Agreement to Acquire Human Immunology Biosciences

      Biogen Bolsters Late-Stage Pipeline, Expands Immunology Portfolio with Agreement to Acquire Human Immunology Biosciences Transaction to include felzartamab, a potential first-in-class...

      May 22 2024
      GlobeNewswire Inc.

      Biogen and Ionis Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic Lateral Sclerosis

      Biogen and Ionis Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic Lateral Sclerosis Development of BIIB105, an investigational antisense oligonucleotide for...

      May 16 2024
      GlobeNewswire Inc.

      Eisai Initiates Rolling Biologics License Application to US FDA for LEQEMBI® (lecanemab-irmb) for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer’s Disease Under the Fast Track Status

      Eisai Initiates Rolling Biologics License Application to US FDA for LEQEMBI® (lecanemab-irmb) for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer’s Disease Under the Fast...

      May 14 2024
      GlobeNewswire Inc.
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-4.5-2.05479452055219219212.268215.49264706DE
      41.20.56258790436213.3219206.145212.75261845DE
      1230.116.3232104121184.4219177.6535203.2667978DE
      26-22.3-9.41722972973236.8244.6177.6532206.33642399DE
      52-1.1-0.510204081633215.6244.6177.6530207.66392625DE
      156-1.1-0.510204081633215.6244.6177.6530207.66392625DE
      260-1.1-0.510204081633215.6244.6177.6530207.66392625DE

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      SHPWShapeways Holdings Inc
      $ 0.5041
      (140.05%)
      		92.14M
      ZAPPZapp Electric Vehicles Group Ltd
      $ 9.25
      (127.27%)
      		105.05M
      IVPInspire Veterinary Partners Inc
      $ 2.94
      (97.32%)
      		54.79M
      VRPXVirpax Pharmaceuticals Inc
      $ 1.10
      (90.31%)
      		161.22M
      MORFMorphic Holding Inc
      $ 55.71
      (74.97%)
      		53.24M
      HLVXHilleVax Inc
      $ 1.63
      (-88.41%)
      		25.64M
      CLEUChina Liberal Education Holdings Ltd
      $ 0.568999
      (-73.90%)
      		15.69M
      SYTSYLA Technologies Company Ltd
      $ 2.07
      (-31.91%)
      		534.24k
      CJETChijet Motor Company Inc
      $ 6.00
      (-25.93%)
      		188.91k
      WETHWetouch Technology Inc
      $ 2.44
      (-22.78%)
      		518.66k
      MAXNMaxeon Solar Technologies Ltd
      $ 0.2722
      (13.42%)
      		493.51M
      NVDANVIDIA Corporation
      $ 128.20
      (1.88%)
      		237.67M
      VRPXVirpax Pharmaceuticals Inc
      $ 1.10
      (90.31%)
      		161.22M
      TSLATesla Inc
      $ 252.94
      (0.56%)
      		157.27M
      SVMHSRIVARU Holding Ltd
      $ 0.1874
      (17.94%)
      		121.48M

      Discussion

      View Full Feed
      kayak_wench kayak_wench 3 minutes ago
      Recall that the IDE Vivos submitted is for an Early Feasibility Medical Device Clinical Study (EFS). Submitting an an EFS was the FDAs recommendation to the company. The EFS Program is open to devices subject to Premarket Approval (PMA), Premarket Notification (510[k]), De Novo classification, or
      RDGL
      DMC8 DMC8 3 minutes ago
      https://ca.finance.yahoo.com/news/lilly-agrees-buy-us-biotech-110605998.html
      AMRN
      Prestotic Prestotic 4 minutes ago
      And please tell me who is deleting my post here Mr moderator. Does an alternate opinion bother you or interupt your plans that much. Leads me to believe that Nebraska and Alaska are correct in their P & D theories.
      VXIT
      Chiugray Chiugray 6 minutes ago
      Norisknorewards, That says it all. “This guy works for citadel”

      The story of NWBO’s journey battling a wolfpack of market manipulators, short minions, naked shorting, spoofing orders, marking-the-closing price, frivolous lawsuits, fake journalists, fake stories, daily FUD postings, ar
      NWBO
      SF971 SF971 8 minutes ago
      Near-term strategy is a Nasdaq uplist.

      CEO has always envisioned "ringing the bell" as one of his life-long goals.

      Question is how quickly they get there as they already have the revenues to support an uplist.
      YCRM
      georgejjl georgejjl 9 minutes ago
      Suddenly, there's talk of 3 rate cuts this year

      3 interest rate cuts would be very good for the US and world economies. Also, very good for AVXL stock.

      https://finance.yahoo.com/news/suddenly-theres-talk-3-rate-024500987.html

      Good luck and GOD bless,
      AVXL
      SF971 SF971 10 minutes ago
      Was anyone here in $GDVM?

      Another cybersecurity company reverse merger with near identical OS to $YCRM.

      A handful of whales led by John Kent locked up the float and walked it up from sub-pennies to .13+ in 6 months.

      Very retail friendly chart and almost e
      GDVM YCRM
      Foodman1291 Foodman1291 11 minutes ago
      Dear Zena

      Good luck with your new neurologist. She sounds like a keeper….

      Stay well

      Foodman
      AVXL
      SF971 SF971 11 minutes ago
      Unlike their other paid promo pumps, they’ve put a muzzle on the CEO and influencers as well (for now).
      YCRM
      Iwasbornpoor Iwasbornpoor 13 minutes ago
      I rest my case.
      PLPL
      Prestotic Prestotic 13 minutes ago
      Neither do you, or I apparently. However, contrary to your statement, the guys on the VXIT team have been sleeping for over two years. Pandemic long gone, even with rising hospitalizations and new variants. Statements about effectiveness of a product, or launching a new website are not enough. VXIT
      VXIT
      Termite7 Termite7 15 minutes ago
      I guess it went higher......for now!!!
      ETHUSD
      NanoEE NanoEE 16 minutes ago
      https://electrek.co/2024/07/08/sk-on-is-working-on-3d-printing-ev-batteries-with-sakuu/

      That is the lithium version.

      The one Sandy is holding up that is Black in a plastic pouch is the Non -Metal Battery. That’s the one we need the specs on.
      XenaLives XenaLives 16 minutes ago
      Yeah - Schwab Sux Big Time...

      SSXBT

      The turmoil caused by transfer of retail accounts alone gave connected institutions a HUGE advantage.
      AVXL
      Lakota-45 Lakota-45 19 minutes ago
      Excellent Summary 'Hawk' - Thanks for chiming in !!!

      ~ Just thinking; The Patient Longs & New Investors are going to be
      "Happy Campers" in the not-so-distant-future !!!

      ~ $WDLF / Decentral Life ~
      WDLF
      Bob Mullet Bob Mullet 19 minutes ago
      SCALING UP IS THE NEW SLAM DUNK AF
      SCALING UP IS THE NEW SLAM DUNK AF SCALING UP IS THE NEW SLAM DUNK AF
      SCALING UP IS THE NEW SLAM DUNK AF
      SCALING UP IS THE NEW SLAM DUNK AF
      SCALING UP IS THE NEW SLAM DUNK AF
      SCALING UP IS THE NEW SLAM DUNK AF
      SCALING UP IS
      KBLB
      DTGoody DTGoody 19 minutes ago
      EXACTLY!!! I have ignored the noise! There is way too much going on here to be on the sidelines. If this goes expert market it will only be temporary. I know when it comes off it will be multi-pennies or multi-silver.
      RSPI
      Bob Mullet Bob Mullet 22 minutes ago
      Do you give more a siht about

      Scaling up
      Doubling up
      Ramping up OR
      Expanding up…..production??

      KBLB
      CanItBThisEZ2Make CanItBThisEZ2Make 22 minutes ago
      BEST SELLERS RANK (BSR) IS 709 5 Estimated Sold on Amazon Since JULY 1 - 3RD Quarter 2024
      https://investorshub.advfn.com/uimage/uploads/2024/4/24/cnxttVOS_5G_GIF.gif
      https://www.amazon.com/Vos-RDGL5GX55-B-01-VOS-5G-Dongle/dp/B0C66KHZLP

      NOTE: In theory, when BSR Value Dec
      SRMX
      TradingCharts TradingCharts 22 minutes ago
      I thought they were graphene but it is Li-metal

      Sakuu's Dry-Printed Li-metal Batteries Hit 1,000 Cycles

      40,889 views Jun 28, 2024 #sakuu #evbatteries
      Sandy and the Munro Live Crew Visit Sakuu for an Update on Their Fully Dry Manufacturing Process, Featuring
      BCM18 BCM18 23 minutes ago
      BLLB is doing what is does as it usually does. Ya know....filing and staying current. Pd got cut to 3 posts a day so he broke out another accnt he been saving for the one stock that gave him trouble. Cmon let's see this 100x they/them claim to be able to pull off.
      I'm READY!
      BLLB
      DTGoody DTGoody 24 minutes ago
      Exhibit 10.2





      NIH SERVICE AGREEMENT



      (2)











      Contents



      1. PROVIDER OBLIGATIONS 3
      2. FEES
      RSPI
      Slim6 Slim6 26 minutes ago
      For the quarter Jan-Mar 2023, POET had net loss of $5.27 million.
      For the quarter, Jan-Mar 2024, POET had net loss of $5.72 million. Those are both huge losses compared to the company's total revenue.
      That is an increase of $450K. These losses are accumulating. POET just increased the
      POET
      Bob Mullet Bob Mullet 26 minutes ago
      So, what you are saying is the news caused massive volume and share price spike??!?
      KBLB
      modes948 modes948 26 minutes ago
      Yes hope so.Nice mail anyway.
      HERB

      Your Recent History

      BIT
      1BIIB
      Biogen
      Delayed Upgrade Clock